Sandra Schmid

Sandra Schmid is an experienced regulatory affairs professional currently serving as the Sr. Director of Regulatory Affairs at iOnctura since February 2025. Prior roles include Sr. Director of Regulatory Affairs at Affimed from August 2022 to February 2025, and Director of Regulatory Affairs at GSK from September 2019 to July 2022. Sandra has also held positions such as Associate Director of Global Regulatory Affairs Oncology at Merck Serono and Sr. Regulatory Affairs Manager at Merz Pharmaceuticals. Earlier career experiences include roles at ImClone Systems and ICON Clinical Research, alongside a research position at Zentrum für Medizinische Forschung. Sandra holds a Dipl.-Ing. in Biotechnology from Technische Hochschule Mannheim, obtained between 1993 and 1998.